Sanofi SA (ADR) (SNY) Reaches $48.79 After 5.00% Down Move; 1 Bullish Analysts Covering Apollo Residential Mortgage (AMTG)

September 11, 2017 - By Adrian Mccoy

The stock of Sanofi SA (ADR) (NYSE:SNY) is a huge mover today! About 605,404 shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 26.96% since September 11, 2016 and is uptrending. It has outperformed by 10.26% the S&P500.The move comes after 6 months negative chart setup for the $123.42B company. It was reported on Sep, 11 by Barchart.com. We have $46.35 PT which if reached, will make NYSE:SNY worth $6.17B less.

Among 2 analysts covering Apollo Residential Mortgage Inc (NYSE:AMTG), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. Apollo Residential Mortgage Inc had 5 analyst reports since August 7, 2015 according to SRatingsIntel. The company was downgraded on Thursday, April 21 by JP Morgan. Maxim Group maintained Apollo Residential Mortgage Inc (NYSE:AMTG) rating on Monday, November 9. Maxim Group has “Buy” rating and $17.25 target. The company was maintained on Monday, August 10 by Maxim Group. See Apollo Residential Mortgage Inc (NYSE:AMTG) latest ratings:

Among 11 analysts covering Sanofi-aventis Sa (NYSE:SNY), 3 have Buy rating, 0 Sell and 8 Hold. Therefore 27% are positive. Sanofi-aventis Sa had 18 analyst reports since October 15, 2015 according to SRatingsIntel. The rating was upgraded by Morgan Stanley to “Overweight” on Thursday, October 15. The firm has “Neutral” rating given on Wednesday, April 12 by JP Morgan. The firm has “Neutral” rating given on Friday, April 21 by JP Morgan. The firm has “Reduce” rating by HSBC given on Friday, April 7. Bernstein downgraded the stock to “Mkt Perform” rating in Monday, November 9 report. The company was maintained on Friday, March 31 by JP Morgan. The stock has “Underperform” rating by BNP Paribas on Thursday, December 10. As per Thursday, September 8, the company rating was upgraded by Berenberg. The firm has “Buy” rating by Argus Research given on Thursday, April 6. The stock has “Overweight” rating by Barclays Capital on Thursday, May 12.

Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The company has market cap of $123.42 billion. The Company’s divisions are Pharmaceuticals, Human Vaccines , and Other. It has a 21.89 P/E ratio. The Pharmaceuticals segment comprises the commercial activities of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.

Apollo Residential Mortgage, Inc. is a holding firm that conducts its business primarily through ARM Operating, LLC and other operating subsidiaries. The company has market cap of $434.73 million. The Firm is primarily engaged in the business of investing in residential mortgage assets in the United States. It currently has negative earnings. The Firm seeks to generate risk-adjusted returns from its assets to its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation.